Equities researchers at StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL – Get Free Report) in a research report issued to clients and investors on Wednesday. The firm set a “sell” ...
The stock market is where investors connect to buy and sell investments — most commonly, stocks, which are shares of ownership in a public company. Many, or all, of the products featured on this ...
IgG MoDE Degraders: BHV-1300 Phase 1 completing last remaining dose cohorts with the optimized subcutaneous formulation with expected completion in 1H 2025. BHV-1310 first-in-human study anticipated ...